Literature DB >> 32002768

Underuse of anticoagulant therapy in hospitalized older patients: comment on the article of Wojszel et al.

Mario Bo1, Enrico Brunetti2, Maddalena Gibello1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32002768     DOI： 10.1007/s11239-020-02050-6

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  11 in total

1.  Effects of oral anticoagulant therapy in older medical in-patients with atrial fibrillation: a prospective cohort observational study.

Authors:  Mario Bo; Federica Li Puma; Marco Badinella Martini; Yolanda Falcone; Marina Iacovino; Enrica Grisoglio; Elena Menditto; Gianfranco Fonte; Enrico Brunetti; Giovanni Carlo Isaia; Fabrizio D'Ascenzo; Fiorenzo Gaita
Journal:  Aging Clin Exp Res       Date:  2016-04-21       Impact factor: 3.636

2.  Health status, geriatric syndromes and prescription of oral anticoagulant therapy in elderly medical in-patients with atrial fibrillation: a prospective observational study.

Authors:  M Bo; F Li Puma; M Badinella Martini; Y Falcone; M Iacovino; E Grisoglio; M Bonetto; G Isaia; G Ciccone; G C Isaia; F Gaita
Journal:  Int J Cardiol       Date:  2015-03-21       Impact factor: 4.164

Review 3.  Practical use of Direct Oral Anti Coagulants (DOACs) in the older persons with atrial fibrillation.

Authors:  Mario Bo; Niccolò Marchionni
Journal:  Eur J Intern Med       Date:  2019-11-15       Impact factor: 4.487

4.  Effects of Oral Anticoagulant Therapy in Medical Inpatients ≥65 Years With Atrial Fibrillation.

Authors:  Mario Bo; Irene Sciarrillo; Federica Li Puma; Marco Badinella Martini; Yolanda Falcone; Marina Iacovino; Enrica Grisoglio; Elena Menditto; Gianfranco Fonte; Enrico Brunetti; Guido Maggiani; Giovanni Carlo Isaia; Fiorenzo Gaita
Journal:  Am J Cardiol       Date:  2015-12-02       Impact factor: 2.778

5.  Influence of Competing Risks on Estimating the Expected Benefit of Warfarin in Individuals with Atrial Fibrillation Not Currently Taking Anticoagulants: The Anticoagulation and Risk Factors in Atrial Fibrillation Study.

Authors:  Jeffrey M Ashburner; Alan S Go; Yuchiao Chang; Margaret C Fang; Lisa Fredman; Katie M Applebaum; Daniel E Singer
Journal:  J Am Geriatr Soc       Date:  2016-11-12       Impact factor: 5.562

6.  A global clinical measure of fitness and frailty in elderly people.

Authors:  Kenneth Rockwood; Xiaowei Song; Chris MacKnight; Howard Bergman; David B Hogan; Ian McDowell; Arnold Mitnitski
Journal:  CMAJ       Date:  2005-08-30       Impact factor: 8.262

7.  The role of comprehensive geriatric assessment and functional status in evaluating the patterns of antithrombotic use among older people with atrial fibrillation.

Authors:  A Mazzone; M Bo; A Lucenti; S Galimberti; G Bellelli; G Annoni
Journal:  Arch Gerontol Geriatr       Date:  2016-04-13       Impact factor: 3.250

8.  Health status, geriatric syndromes and prescription of oral anticoagulant therapy in elderly medical inpatients with atrial fibrillation.

Authors:  Mario Bo; Irene Sciarrillo; Guido Maggiani; Yolanda Falcone; Marina Iacovino; Enrica Grisoglio; Gianfranco Fonte; Simon Grosjean; Fiorenzo Gaita
Journal:  Geriatr Gerontol Int       Date:  2016-01-28       Impact factor: 2.730

Review 9.  Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis.

Authors:  Ying Bai; Shi-Dong Guo; Hai Deng; Alena Shantsila; Laurent Fauchier; Chang-Sheng Ma; Gregory Y H Lip
Journal:  Age Ageing       Date:  2018-01-01       Impact factor: 10.668

10.  Determinants of anticoagulant therapy in atrial fibrillation at discharge from a geriatric ward: cross sectional study.

Authors:  Z B Wojszel; A Kasiukiewicz
Journal:  J Thromb Thrombolysis       Date:  2020-01       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.